Denali Therapeutics Inc. (DNLI): 10-Q filed Nov 3, 2026

Form type

10-Q

Filing date

Nov 3, 2026

Accession number

0001714899-26-000109

Filer

Denali Therapeutics Inc. (CIK 1714899)